AMA, APHA, ASHP, Call for Immediate End to Prescribing, Dispensing, and Use of Ivermectin to Prevent or Treat COVID-19 Outside Clinical Trials Following the FDA/CDC warning against the use of Ivermectin to prevent and treat COVID-19, the American Medical Association and other health care organizations issued a joint statement calling for an immediate end to the ordering, prescribing or dispensing of ivermectin for prevention or treatment of COVID-19. WASHINGTON, DC - The American Medical Association (AMA), American Pharmacists Association (APhA), and American Society of Health-System Pharmacists (ASHP) strongly oppose the ordering, prescribing, or dispensing of ivermectin to prevent or treat COVID-19 outside of a clinical trial. Ivermectin is approved by the U.S. Food and Drug Administration (FDA) ... September 2, 2021 AMA, COVID19, Drug Prescribing/Dispensing, Patient Care, Public Health AMA, APHA, ASHP, COVID-19, Ivermectin, Prescription 0 0 Comment Read More »
